Cargando…

A Paradigm Shift in Primary Liver Cancer Therapy Utilizing Genomics, Molecular Biomarkers, and Artificial Intelligence

SIMPLE SUMMARY: Primary liver tumors impose significant patient morbidity and mortality with overall poor prognosis. To date, conventional therapies have provided only modest survival benefit to patients. Developments in genomics, molecular biomarkers, and artificial intelligence are introducing nov...

Descripción completa

Detalles Bibliográficos
Autores principales: Moroney, James, Trivella, Juan, George, Ben, White, Sarah B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216313/
https://www.ncbi.nlm.nih.gov/pubmed/37345129
http://dx.doi.org/10.3390/cancers15102791